Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NBY | US
-0.15
-10.79%
Healthcare
Biotechnology
30/06/2024
09/03/2026
1.24
1.38
1.38
1.11
NovaBay Pharmaceuticals Inc. a biopharmaceutical company develops and sells eyecare skincare and wound care products in the United States and internationally. It offers Avenova Spray a solution for removing foreign materials including microorganisms and debris from skin around the eye such as the eyelid; and wound care products which are used for cleansing and irrigation as part of surgical procedures as well as treating certain wounds burns ulcers and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris rosacea and eczema anti-aging hyperhidrosis excessive hair and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors as well as online. The company was formerly known as NovaCal Pharmaceuticals Inc. and changed its name to NovaBay Pharmaceuticals Inc. in February 2007. NovaBay Pharmaceuticals Inc. was incorporated in 2000 and is headquartered in Emeryville California.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
161.8%1 month
184.2%3 months
380.4%6 months
286.8%-
-
0.29
-3.26
0.51
-0.34
0.30
-
-5.03M
6.06M
6.06M
-
-43.88
-
-32.10
-282.96
0.06
9.25
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.69
Range1M
2.37
Range3M
19.52
Rel. volume
0.96
Price X volume
629.27K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| KPRX | KPRX | Biotechnology | 2.14 | 6.36M | 8.08% | 0.21 | 0.25% |
| Curis Inc | CRIS | Biotechnology | 1.03 | 6.16M | 4.04% | n/a | -6039.91% |
| Alaunos Therapeutics Inc | TCRT | Biotechnology | 3.65 | 5.84M | 1.11% | n/a | 0.00% |
| Moleculin Biotech Inc | MBRX | Biotechnology | 1.96 | 5.58M | -5.77% | n/a | 3.00% |
| Genprex Inc | GNPX | Biotechnology | 1.98 | 5.13M | 1.54% | n/a | 0.00% |
| Immuron Limited | IMRN | Biotechnology | 0.8349 | 5.07M | -5.13% | n/a | 1.37% |
| QNCX | QNCX | Biotechnology | 0.1065 | 4.61M | 4.11% | n/a | 30.62% |
| Jaguar Health Inc | JAGX | Biotechnology | 0.491 | 4.54M | -16.85% | 0.25 | 176.14% |
| Neurotrope Inc | NTRP | Biotechnology | 2.86 | 4.53M | -2.39% | n/a | 0.00% |
| BioCardia Inc | BCDA | Biotechnology | 1.28 | 4.48M | 8.47% | n/a | -58.03% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 3.98 | 6.06M | -4.33% | n/a | 204.46% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.47 | 3.75M | -0.67% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.39 | 3.71M | -1.76% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.46 | 1.36M | 2.93% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.008 | 737.72K | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.34 | 0.53 | Cheaper |
| Ent. to Revenue | 0.30 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.29 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 380.36 | 72.80 | Riskier |
| Debt to Equity | -3.26 | -1.23 | Cheaper |
| Debt to Assets | 0.51 | 0.25 | Expensive |
| Market Cap | 6.06M | 3.66B | Emerging |